It's almost 2026, and soon you'll be receiving your year-end statements for all your investment accounts. You'll also hear a ...

We look back to look forward and predict whether three of 2025's biggest disappointments can turn it around in 2026.

In this podcast, Motley Fool co-founder David Gardner highlights 10 standout Motley Fool Rule Breakers episodes from this ...

MIchaelAaron Flicker is the co-author of "Hacking The Human Mind: The Behavioral Science Secrets Behind 17 of the World's ...

Keri A. August stated, "ground beef costs will continue to increase throughout the remainder of fiscal year 2025," indicating ...

Freehold Royalties’ 8% yield can make your TFSA feel like “payday season,” but that monthly cheque is tied to energy cycles, ...

The first step in Buffett's test is to determine if the earnings for a stock can be estimated for at least five years into ...

Now, it’s worth noting Stock Advisor’s total average return is 986 % — a market-crushing outperformance compared to 196% for ...

Shares of Praxis Precision Medicines (NASDAQ: PRAX) leaped on Monday after the clinical-stage biopharmaceutical company ...

Now, it’s worth noting Stock Advisor’s total average return is 991 % — a market-crushing outperformance compared to 196% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

Rivian is using custom-designed chips to power its in-vehicle computations. The company also announced a new autonomous driving service. These 10 Stocks Could Mint the Next Wave of Millionaires › The ...

Axsome just received priority review designation for its most important drug. Auvelity is an oral medication already approved ...